1. WHO: Multidrug and Extensively drug-resistant TB: 2010 Global Report on Surveillance and Response. 2010,
http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
,
2. Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis. [
http://www.who.int/tb/features_archive/policy_statement.pdf
]
3. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Drug Resistant Tuberculosis: Policy Statement. [
http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf
]
4. Shah NS, Lan NT, Huyen MN, Laserson K, Iademarco MF, Binkin N, Wells C, Varma JK: Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam. Int J Tuberc Lung Dis. 2009, 13 (2): 247-252.
5. Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, Buu TN, Kremer K, Hang PT, Caws M, et al: Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis. 2010, 10: 149-10.1186/1471-2334-10-149.